MedWatch

Leo Pharma sells app firm

Omhu, a spinout from Leo Innovation Lab that has developed a dermatology app to monitor skin diseases, has been sold off to US-based Medable.

Christian Sejersen, now former CEO of Omhu and new site lead for Medable Compenhagen | Photo: Mathilde Gilling / Leo Innovation Lab / PR

One year ago, Omhu, a company which develops telemedical apps, was ready to spread its wings and was therefore spun out of Leo Innovation Lab.

Omhu had barely had the chance to leave the nest, though, before it was taken under someone else’s wing. Leo Pharma has just sold the company to US-based Medable, a press release from the latter firm announces.

In the statement, Medable highlights that Omhu’s origins at the Leo Innovation Lab as a valuable mark of quality.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Britt Meelby Jensen wants to rebuild trust in Ambu

After a turbulent time for Ambu under Juan Jose Gonzalez’s reign, new chief executive appointee Britt Meelby Jensen aims to rebuild the trust in the medtech firm, which has downgraded its expectations seven times over the past three years.

Outgoing Ambu CEO commends colleagues

”A true privilege,” says Juan Jose Gonzalez, describing his time as CEO at Ambu, which came to an end with Thursday’s announcement that Britt Meelby Jensen would take over the role.

Further reading

Related articles

Latest news

See all jobs